Drug Lawsuit Update: Xarelto, Pradaxa and Eliquis
There are three blood thinners currently on the market, Xarelto, Pradaxa and Eliquis that have been receiving attention due to their aggressive marketing by pharmaceutical companies and frequent television commercials from national personal injury firms. Xarelto, Pradaxa and Eliquis are anticoagulant medications that are generally given to people who have a high risk of stroke. By preventing blood clots, these medications help prevent strokes. They have been marketed as superior to a very popular blood thinner, Wayfarin, which requires the patient to be frequently monitored to make sure that certain vitamin levels in blood stay within certain parameters.
Once Xarelto, Pradaxa or Eliquis are administered they can lead to a horrible side effect: uncontrollable bleeding. What makes these drugs so risky is the fact that there is no approved means to reverse the effects of the anticoagulant in the event bleeding occurs. This means that minor cuts or internal bleeding can potentially be fatal when using these drugs. All three drug manufacturers have lawsuits filed against them that claim that the makers of the drugs did not adequately warn patients about the risks associated with using the medications.
Most of the Pradaxa lawsuits settled in May 2014. The manufacturer, Boehringer Ingelheim, announced that it would pay $650 million to settle the approximately 4,000 state and federal lawsuits that had been filed for deaths and injuries that it alleged caused. The manufacturers of Xarelto and Eliquis are now facing lawsuits regarding the improper warnings given to patients.
If you or anyone you love has been injured by taking any of these blood thinners, please do not hesitate to call the Law Offices of David I. Pankin, P.C. at 888-529-9600 to find out your legal rights.